Publications en collaboration avec des chercheurs de Helsinki University Central Hospital (34)

2024

  1. Recent outcomes of liver transplantation for Budd-Chiari syndrome: A study of the European Liver Transplant Registry (ELTR) and affiliated centers

    Hepatology, Vol. 80, Núm. 1, pp. 136-151

2022

  1. Axillary surgery after neoadjuvant therapy in initially node-positive breast cancer: international EUBREAST survey

    The British journal of surgery, Vol. 109, Núm. 9, pp. 857-863

  2. Germline ERCC excision repair 6 like 2 (ERCC6L2) mutations lead to impaired erythropoiesis and reshaping of the bone marrow microenvironment

    British Journal of Haematology, Vol. 199, Núm. 5, pp. 754-764

  3. Outcome of allogeneic haematopoietic cell transplantation in eosinophilic disorders: A retrospective study by the chronic malignancies working party of the EBMT

    British Journal of Haematology

  4. Sex differences in COVID-19 mortality risk in patients on kidney function replacement therapy

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Isatuximab as monotherapy and combined with dexamethasone in patients with relapsed/refractory multiple myeloma

    Blood, Vol. 137, Núm. 9, pp. 1154-1165

  2. Pressure injury prediction models for critically-ill patients should consider both the case-mix and local factors

    Intensive and Critical Care Nursing

  3. Surgical management of the axilla in clinically node‐positive breast cancer patients converting to clinical node negativity through neoadjuvant chemotherapy: Current status, knowledge gaps, and rationale for the eubreast‐03 axsana study

    Cancers, Vol. 13, Núm. 7

2020

  1. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

    Journal for ImmunoTherapy of Cancer, Vol. 8, Núm. 1

  2. Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma

    Leukemia and Lymphoma, Vol. 61, Núm. 8, pp. 1850-1859

  3. Surgical Outcome and Oncological Survival of Osteofibrous Dysplasia-Like and Classic Adamantinomas: An International Multicenter Study of 318 Cases

    The Journal of bone and joint surgery. American volume, Vol. 102, Núm. 19, pp. 1703-1713

  4. The requirements of a specialist breast centre

    Breast

2019

  1. About the French prohibition of textured breast implants: is it justified or over-cautious? The EUSOMA, ESSO/BRESSO position

    Breast

  2. Corrigendum to “About the French prohibition of textured breast implants: Is it justified or over-cautious? The EUSOMA, ESSO/BRESSO position” (The Breast (2019) 46 (95–96), (S0960977619304990), (10.1016/j.breast.2019.05.005))

    Breast

  3. Corrigendum to “EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants” (The Breast (2019) 44 (90–93), (S0960977619300116), (10.1016/j.breast.2019.01.011))

    Breast

  4. EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants

    Breast, Vol. 44, pp. 90-93

  5. European Society of Surgical Oncology's strategy for clinical research: Paving the way for a culture of research in cancer surgery

    European Journal of Surgical Oncology, Vol. 45, Núm. 9, pp. 1515-1519

  6. European guidelines on the organisation of breast centres and voluntary certification processes

    Breast Care, Vol. 14, Núm. 6, pp. 359-365

  7. Variability in breast cancer surgery training across Europe: An ESSO-EUSOMA international survey

    European Journal of Surgical Oncology, Vol. 45, Núm. 4, pp. 567-572

2018

  1. Risk factors for unfavourable postoperative outcome in patients with Crohn's disease undergoing right hemicolectomy or ileocaecal resection. An international audit by ESCP and S-ECCO

    Colorectal Disease, Vol. 20, Núm. 3, pp. 219-227